Genetic alterations of histone lysine methyltransferases and their significance in breast cancer
about
A Comparative Analysis of Genetic and Epigenetic Events of Breast and Ovarian Cancer Related to TumorigenesisFibroblast growth factor receptors in breast cancer.iGC-an integrated analysis package of gene expression and copy number alteration.Two Loops Undergoing Concerted Dynamics Regulate the Activity of the ASH1L Histone Methyltransferase.Coordination of stress signals by the lysine methyltransferase SMYD2 promotes pancreatic cancer.Setdb1, a novel interactor of ΔNp63, is involved in breast tumorigenesisWHSC1L1 drives cell cycle progression through transcriptional regulation of CDC6 and CDK2 in squamous cell carcinoma of the head and neck.Integrative genomic and transcriptomic analysis for pinpointing recurrent alterations of plant homeodomain genes and their clinical significance in breast cancer.The Histone Methyltransferase Ash1l is Required for Epidermal Homeostasis in Mice.The NSD family of protein methyltransferases in human cancer.Mutation spectra of histone methyltransferases with canonical SET domains and EZH2-targeted therapy.Differences between BCL2-break positive and negative follicular lymphoma unraveled by whole exome sequencing.Chromatin remodelling and DNA repair genes are frequently mutated in endometrioid endometrial carcinoma.H3K36 methyltransferases as cancer drug targets: rationale and perspectives for inhibitor developmentDysregulation of histone methyltransferases in breast cancer - Opportunities for new targeted therapies?Therapeutical potential of deregulated lysine methyltransferase SMYD3 as a safe target for novel anticancer agents.Emerging role of SETDB1 as a therapeutic target.Characterization of potential driver mutations involved in human breast cancer by computational approaches.Residual expression of SMYD2 and SMYD3 is associated with the acquisition of complex karyotype in chronic lymphocytic leukemia.Genetic alterations of KDM4 subfamily and therapeutic effect of novel demethylase inhibitor in breast cancer.Identification and characterization of PKF118-310 as a KDM4A inhibitor.Mrg15 stimulates Ash1 H3K36 methyltransferase activity and facilitates Ash1 Trithorax group protein function in Drosophila.Smad3-mediated recruitment of the methyltransferase SETDB1/ESET controls Snail1 expression and epithelial-mesenchymal transition.miR-126-5p promotes retinal endothelial cell survival through SetD5 regulation in neurons.Silencing of retrotransposons by SETDB1 inhibits the interferon response in acute myeloid leukemia.Peptide inhibition of the SETD6 methyltransferase catalytic activity.Lysine methyltransferase SMYD2 promotes triple negative breast cancer progression.Suv4-20h1 promotes G1 to S phase transition by downregulating p21WAF1/CIP1 expression in chronic myeloid leukemia K562 cells.Genome-wide multi-omics profiling of the 8p11-p12 amplicon in breast carcinoma.The role of histone lysine methyltransferase NSD3 in cancer
P2860
Q26746952-18A05689-620E-41D6-B94C-401CF1B5259EQ34556066-F21BBC06-44FE-4D0E-BF68-B9522A072DE2Q36249808-2C5EBF81-CC40-4356-B08B-92171451AF6AQ36332254-8A5EB996-EC13-48BF-8BBB-146E0246ED66Q36783008-76D4D23F-386D-40D2-97B0-A5E42DE45DCFQ37301684-266A44F7-7035-482F-878F-7F194E4A49EBQ37520610-E63B261D-7166-4AB2-979F-E8053B1BCD89Q37706554-093AA8D3-97F9-42AA-B8A8-BD934EC51633Q37736756-1A9B2F5D-6AF2-4953-B457-AFC94B2C5F85Q38459795-5C42A983-443A-49E0-AC63-C2EEF246C723Q38594002-F07C763F-4C03-4573-8738-827075BF97E1Q38616932-8458445B-3841-4414-82B3-4B69BF89E9E2Q38725254-D5B19D95-A1CC-4D4F-ABA8-393993B78A67Q38829055-0B1CE9F9-3CEE-43B6-AA50-7681E6B0C047Q38975402-4AD95206-F9D5-47C0-B977-7262A21F9749Q39055609-EA0799CF-416E-4536-AEBA-1FF86C843B0AQ39079803-A482FF68-C1C8-4346-8560-F49ED54D835AQ39286993-8751C683-EAB8-4D2B-8D62-618E1897F42AQ40083143-A66BFB20-D60F-49F5-BEA4-2091FF846425Q42027790-A3CA0382-EFEF-41DF-AF01-FBB9E0D609B9Q42358298-28C1FDAA-9652-4A15-82F1-DB08FC73D6FFQ45754918-47026562-61F3-4259-81C4-2DC55B5BEEC8Q46132614-3529A3DC-85F7-480B-AC62-D5FCCA5E375BQ47358717-0C6A467D-8583-4B99-8A84-89FFACBDF0CEQ47831063-098AD6FB-6BAA-4DFF-8E5D-240906979B7CQ50052960-DC1B5D39-F4A7-42FF-AEF6-85AF409F473FQ52682420-FA747AD9-435E-4A49-BA68-A933BE97C41BQ52721822-27DD06F3-5686-4265-BB47-55842AEB08E7Q55409765-8E65E14B-7CD3-40B6-95AA-3F1AF1CC0159Q57177118-776AA6C0-C0AD-48F1-A4A1-7B26C4175F1E
P2860
Genetic alterations of histone lysine methyltransferases and their significance in breast cancer
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Genetic alterations of histone ...... significance in breast cancer
@ast
Genetic alterations of histone ...... significance in breast cancer
@en
type
label
Genetic alterations of histone ...... significance in breast cancer
@ast
Genetic alterations of histone ...... significance in breast cancer
@en
prefLabel
Genetic alterations of histone ...... significance in breast cancer
@ast
Genetic alterations of histone ...... significance in breast cancer
@en
P2093
P2860
P356
P1433
P1476
Genetic alterations of histone ...... significance in breast cancer
@en
P2093
Andreana Holowatyj
Lanxin Liu
Sarah Kimball
Zeng-Quan Yang
P2860
P304
P356
10.18632/ONCOTARGET.2967
P407
P577
2015-02-01T00:00:00Z